Reply to 'fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopause requiring careful evaluation of the benefit-risk balance'.

Autor:	Roberts, Megan Z., Andrus, Miranda R.
Předmět:	VASOMOTOR system MENOPAUSE
Zdroj:	Expert Opinion on Pharmacotherapy; Oct2024, Vol. 25 Issue 14, p1973-1974, 2p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu